|
Sign In to gain access to subscriptions and/or personal tools.
|
Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 7, No. 1 suppl,
S3-S6 (2002)
DOI: 10.1177/107424840200700102
© 2002 SAGE Publications
Methods of Evaluation and Quantification of Microangiopathy in High Perfusion Microangiopathy (Chronic Venous Insufficiency and Diabetic Microangiopathy)
M. T. DeSanctis, MD
M. R. Cesarone, MD
L. Incandela, MD
G. Belcaro, MD, PhD
G. Acerbi, MD
Irvine2 Vasc Lab and Physiology, Department of Biomedical Sciences, Chieti University, San Valentino Vascular Screening Project, Italy, Vasc Unit, Ealing Hospital and Irvine Vasc Lab, St Mary's Hospital, Imperial College, London, UK
Noninvasive macro- and microcirculatory tests provide quantitative information that offers answers to most questions posed in venous diseases. Duplex scanning is used to assess the macrocirculation, and microcirculatory methods are used to assess and quantify venous microangiopathy. Laser Doppler flowmetry is used to assess perfusion. Transcutaneous Po2 and Pco2 measurements are used to study venous hypertension, and strain-gauge plethysmography is used to assess capillary filtration. In venous hypertension, fluid filtration into the extracapillary compartment is increased. The increase in filtration is associated with a decreased venoarteriolar response. To quantify capillary filtration, two methods have been developed: venous occlusion plethysmography and rate of ankle swelling. These methods quantify filtration into the extracapillary compartment and, therefore, are an indication of the formation of edema, the most frequent sign in venous hypertension. Other methods, such as the vacuum suction chamber and the edema tester, can be used to assess changes due to treatments in venous hypertension. The techniques described in this article should be used in controlled environmental conditions
Key Words: noninvasive investigations laser Doppler strain-gauge plethysmography venous hypertension diabetic microangiopathy capillary filtration venous microangiopathy edema varicose veins

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Belcaro, M. Rosaria Cesarone, A. Ledda, M. Cacchio, I. Ruffini, A. Ricci, E. Ippolito, A. Di Renzo, M. Dugall, M. Corsi, et al.
O-({beta}-Hydroxyethyl)-Rutosides Systemic and Local Treatment in Chronic Venous Disease and Microangiopathy: An Independent Prospective Comparative Study
Angiology,
March 1, 2008;
59(1_suppl):
7S - 13S.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Belcaro, M. R. Cesarone, A. Ledda, M. Cacchio, I. Ruffini, A. Ricci, E. Ippolito, A. Di Renzo, M. Dugall, M. Corsi, et al.
5-Year Control and Treatment of Edema and Increased Capillary Filtration in Venous Hypertension and Diabetic Microangiopathy Using O-({beta}-Hydroxyethyl)-Rutosides: A Prospective Comparative Clinical Registry
Angiology,
March 1, 2008;
59(1_suppl):
14S - 20S.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Cesarone, G. Belcaro, P. Rohdewald, L. Pellegrini, A. Ledda, G. Vinciguerra, A. Ricci, G. Gizzi, E. Ippolito, F. Fano, et al.
Rapid Relief of Signs/Symptoms in Chronic Venous Microangiopathy With Pycnogenol(R): A Prospective, Controlled Study.
Angiology,
October 1, 2006;
57(5):
569 - 576.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Cesarone, G. Belcaro, P. Rohdewald, L. Pellegrini, A. Ledda, G. Vinciguerra, A. Ricci, G. Gizzi, E. Ippolito, F. Fano, et al.
Improvement of diabetic microangiopathy with pycnogenol: A prospective, controlled study.
Angiology,
August 1, 2006;
57(4):
431 - 436.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Cesarone, G. Belcaro, P. Rohdewald, L. Pellegrini, A. Ledda, G. Vinciguerra, A. Ricci, G. Gizzi, E. Ippolito, F. Fano, et al.
Comparison of Pycnogenol(R) and Daflon(R) in Treating Chronic Venous Insufficiency: A Prospective, Controlled Study
Clinical and Applied Thrombosis/Hemostasis,
April 1, 2006;
12(2):
205 - 212.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Cesarone, G. Belcaro, L. Pellegrini, A. Ledda, G. Vinciguerra, A. Ricci, A. Di Renzo, I. Ruffini, G. Gizzi, E. Ippolito, et al.
Venoruton(R) vs Daflon(R): Evaluation of Effects on Quality of Life in Chronic Venous Insufficiency
Angiology,
March 1, 2006;
57(2):
131 - 138.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Belcaro, M. R. Cesarone, B. M. Errichi, A. Ledda, A. Di Renzo, S. Stuard, M. Dugall, L. Pellegrini, P. Rohdewald, E. Ippolito, et al.
Venous Ulcers: Microcirculatory Improvement and Faster Healing with Local Use of Pycnogenol(R)
Angiology,
November 1, 2005;
56(6):
699 - 705.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Belcaro, M. R. Cesarone, G. Vinciguerra, A. Ledda, M. Dugall, A. Di Renzo, S. Stuard, A. Ricci, M. Cacchio, E. Ippolito, et al.
A Plaster Combining Diclofenac and Heparin: Microcirculatory Evaluation in 2 Models of High-Perfusion Microangiopathy
Angiology,
November 1, 2005;
56(6):
707 - 713.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Cesarone, G. Belcaro, L. Pellegrini, A. Ledda, G. Vinciguerra, A. Ricci, G. Gizzi, E. Ippolito, F. Fano, M. Dugall, et al.
HR, 0-(Beta-Hydroxyethyl)-Rutosides; (Venoruton(R)): Rapid Relief of Signs/Symptoms in Chronic Venous Insufficiency and Microangiopathy: A Prospective, Controlled Study
Angiology,
March 1, 2005;
56(2):
165 - 172.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Cesarone, G. Belcaro, L. Pellegrini, A. Ledda, A. Di Renzo, G. Vinciguerra, A. Ricci, G. Gizzi, E. Ippolito, F. Fano, et al.
HR, 0-(Beta-Hydroxyethyl)-Rutosides, in Comparison with Diosmin+Hesperidin in Chronic Venous Insufficiency and Venous Microangiopathy: An Independent, Prospective, Comparative Registry Study
Angiology,
January 1, 2005;
56(1):
1 - 8.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Cesarone, A. Ricci, A. Di Renzo, G. Belcaro, and M. Dugall
Efficacy of Topical Treatment with Aescin + Essential Phospholipids Gel on Capillary Fragility
Angiology,
November 1, 2004;
55(6_suppl):
S23 - S25.
[Abstract]
[PDF]
|
 |
|
|